Clinical Trials Browser

Unknown × Interventional × Vorinostat × Clear all

Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma

NCT03561259 2023-02-16

OPTIMUM

Phase 2 Unknown

60 enrolled

CNS

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT01554852 2018-06-11

Myeloma XI

Phase 3 Unknown

4,420 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02943642 2016-10-25

Resimmune®

Phase 2 Unknown

162 enrolled

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT00416130 2013-12-10

Clinical Trial of SAHA in Patients With Breast Cancer

Phase 1/2 Unknown

49 enrolled

Breast

Breast Neoplasms

NCT00866762 2011-12-12

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Phase 2 Unknown

60 enrolled

Myeloid

Hematologic Diseases, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

NCT01039363 2009-12-25

Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia

Phase 2 Unknown

27 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT00772798 2008-10-15

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

Phase 2 Unknown

70 enrolled

Gynecologic

Ovarian Neoplasms

Clinical Trials

NYMC195

OPTIMUM

Myeloma XI

Resimmune®

Clinical Trial of SAHA in Patients With Breast Cancer

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer